Clinical Trial Update: Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Tegio consolidation therapy in nasopharyngeal carcinoma patients at high risk of metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Tegio

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN